Aminazin en es it fr

Aminazin Brand names, Aminazin Analogs

Aminazin Brand Names Mixture

  • No information avaliable

Aminazin Chemical_Formula


Aminazin RX_link

No information avaliable

Aminazin fda sheet

Aminazin msds (material safety sheet)

Aminazin Synthesis Reference

No information avaliable

Aminazin Molecular Weight

284.42 g/mol

Aminazin Melting Point

< 25 oC

Aminazin H2O Solubility

14.2 mg/L

Aminazin State


Aminazin LogP


Aminazin Dosage Forms

Tablet; Oral liquid; Injection

Aminazin Indication

Used as an adjunct for short term treatment of moderate and severe psychomotor agitation. Also used to treat agitation or restlessness in the elderly.

Aminazin Pharmacology

Promazine belongs to a group of medications known as the phenothiazine antipsychotics. It acts by blocking a variety of receptors in the brain, particularly dopamine receptors. Dopamine is involved in transmitting signals between brain cells. When there is an excess amount of dopamine in the brain it causes over-stimulation of dopamine receptors. These receptors normally act to modify behaviour and over-stimulation may result in psychotic illness. Promazine hydrochloride blocks these receptors and stops them becoming over-stimulated, thereby helping to control psychotic illness. Promazine has weak extrapyramidal and autonomic side effects which lead to its use in the elderly, for restless or psychotic patients. Its anti-psychotic effect is also weaker and it is not useful in general psychiatry.

Aminazin Absorption

Absorption may be erratic and peak plasma concentrations show large interindividual differences.

Aminazin side effects and Toxicity

Side effects include: extrapyramidal symptoms, drowsiness, weight gain, dry mouth, constipation, endocrine effects (such as gynaecomastia and menstrual disturbance), sensitivity to sunlight and haemolytic anaemia.

Aminazin Patient Information

No information avaliable

Aminazin Organisms Affected

Humans and other mammals